Connection

Perry Molinoff to Radioligand Assay

Back to Details
This is a "connection" page, showing publications Perry Molinoff has written about Radioligand Assay.
Perry Molinoff
Connection Strength
0.454
Radioligand Assay
  1. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. Mol Pharmacol. 1986 Oct; 30(4):329-37.
    View in: PubMed
    Score: 0.068
  2. A comprehensive method for the quantitative determination of dopamine receptor subtypes. Ann N Y Acad Sci. 1984; 430:77-90.
    View in: PubMed
    Score: 0.056
  3. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 1981 Jul 27; 29(4):313-30.
    View in: PubMed
    Score: 0.047
  4. Lack of discrimination by agonists for D2 and D3 dopamine receptors. Neuropsychopharmacology. 1995 Jul; 12(4):335-45.
    View in: PubMed
    Score: 0.031
  5. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells. J Pharmacol Exp Ther. 1994 Apr; 269(1):246-55.
    View in: PubMed
    Score: 0.028
  6. Paradoxical regulation of dopamine receptors in transfected 293 cells. Mol Pharmacol. 1993 Aug; 44(2):371-9.
    View in: PubMed
    Score: 0.027
  7. Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol. 1993 May; 43(5):666-76.
    View in: PubMed
    Score: 0.027
  8. Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists. Mol Pharmacol. 1992 Sep; 42(3):464-70.
    View in: PubMed
    Score: 0.025
  9. Comparison of the expression, transcription and genomic organization of D2 dopamine receptors in outbred and inbred strains of rat. Brain Res. 1992 Jul 03; 584(1-2):45-54.
    View in: PubMed
    Score: 0.025
  10. Effects of mono-, di-, and triamines on the N-methyl-D-aspartate receptor complex: a model of the polyamine recognition site. Mol Pharmacol. 1992 Apr; 41(4):785-92.
    View in: PubMed
    Score: 0.025
  11. Characterization of binding sites for 3H-spiroperidol in human retina. Invest Ophthalmol Vis Sci. 1988 May; 29(5):687-94.
    View in: PubMed
    Score: 0.019
  12. Evaluation of models for analysis of radioligand binding data. Mol Pharmacol. 1987 Jan; 31(1):103-11.
    View in: PubMed
    Score: 0.017
  13. Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers. J Pharmacol Exp Ther. 1985 Sep; 234(3):561-8.
    View in: PubMed
    Score: 0.016
  14. Assay of dopamine receptors with [alpha-3H]flupenthixol. J Pharmacol Exp Ther. 1985 Jan; 232(1):57-61.
    View in: PubMed
    Score: 0.015
  15. In vitro interactions of agonists and antagonists with beta-adrenergic receptors. Biochem Pharmacol. 1984 Mar 15; 33(6):869-75.
    View in: PubMed
    Score: 0.014
  16. Characterization of binding sites for [125I]R(+)trans-7-OH-PIPAT in rat brain. Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec; 350(6):611-7.
    View in: PubMed
    Score: 0.007
  17. Characterization of a mouse beta 1-adrenergic receptor genomic clone. DNA Cell Biol. 1993 Jul-Aug; 12(6):537-47.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.